Effects of ILTG on DAPK1 promoter methylation in colon and leukemia cancer cell lines.
Zorko
Bryan A
BA
Division of Pharmacy Practice and Administration, College of Phamacy, The Ohio State University, Columbus, OH 43210-1291, USA.
Pérez
Lynette Bueno
LB
De Blanco
Esperanza J Carcache
EJ
D051017:Apoptosis Regulatory Proteins / Q000037:antagonists & inhibitors / Q000235:genetics*; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000037:antagonists & inhibitors / Q000235:genetics*; D047188:Chalcones / Q000494:pharmacology*; D003110:Colonic Neoplasms / Q000201:enzymology* / Q000235:genetics*; D019175:DNA Methylation / Q000187:drug effects*; D064550:Death-Associated Protein Kinases; D004791:Enzyme Inhibitors / Q000494:pharmacology; D018922:HL-60 Cells; D019073:HT29 Cells; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000201:enzymology* / Q000235:genetics*; D011401:Promoter Regions, Genetic / Q000187:drug effects
D051017:Apoptosis Regulatory Proteins; D047188:Chalcones; D004791:Enzyme Inhibitors; C040920:isoliquiritigenin; C579096:DAPK1 protein, human; D064550:Death-Associated Protein Kinases; D017871:Calcium-Calmodulin-Dependent Protein Kinases